Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4186917 | Journal of Affective Disorders | 2010 | 7 Pages |
Abstract
In this analysis, ziprasidone significantly improved both depressive and manic mood symptoms in patients with dysphoric mania, suggesting that it might be a useful treatment option in this patient population. Further prospective controlled trials are needed to confirm these findings.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
S. Stahl, I. Lombardo, A. Loebel, F.S. Mandel,